External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

SITC 2024

-
Coming soon
03:00 PM
Duration 10hrs Houston, Texas
Harnessing the cancer immunity cycle via machine learning models to generate novel strategies for personalized cancer therapy
Aghababazadeh FA, Alonso L, Lopez-de-Castro M, Guinot F, Desponds J, Bergmann E, Jones N, Ott SI, Furger S, Karapetyan A, Sankarlingam V, Chithambaram S, Gautschi P, Vasudevan G, Chandler S, Mohindra R, Garaonce-Hediger R, Fontes M, Karanikas V, Crespo M, MacPherson C, Haibe-Kains B, Hernaez M, Armananzas R, Szabados B

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
11:00 PM
Duration 10hrs Houston, Texas
Proteomic analysis in patients with immune checkpoint inhibitor (ICI) associated cardiotoxicity
Mohindra R, Fairfax BP, Kaul M, Chandler SG, Roth AB

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
02:30 AM
Duration 12hrs Houston, Texas
Association between polygenic risk for thyroid dysfunction, calculated from tumor panel sequencing, immune-related thyroid toxicity and overall survival in cancer immunotherapy-treated NSCLC patients
Ebot E, Jin D, Bray D, Frampton G, Fabrizio D, Graham-Siegenthale K, Walls R, Kreutzfeldt-Jensen P, Hamzic S, Chandler S, Mohindra R, Adams C, McCarthy M, Hamner C

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar